Archives for December 19, 2023

← 2023
FDA approves Arcutis’ skin foam for seborrheic dermatitis

FDA approves Arcutis’ skin foam for seborrheic dermatitis

By Jonathan Smith

The US Food and Drug Administration (FDA) has approved a topical foam developed by Arcutis Biotherapeutics and branded as Zoryve for the skin condition seborrheic dermatitis in people aged nine years and up.

Hired and retired: New appointments in the pharma industry

Hired and retired: New appointments in the pharma industry

By Isabel Cameron

BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers, shakers and key announcements in the pharma industry. From Stand Up To Cancer, Astraveus and KBI Biopharma, we break down the key changes.